My watch list

Sincalide


Sincalide
Systematic (IUPAC) name
3-[[2-[[2-[[2-[[2-[[2-[(2-amino-3-carboxy-propanoyl) amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-4- methylsulfanyl-butanoyl]amino]acetyl]amino]-3- (1H-indol-3-yl)propanoyl]amino]-4-methylsulfanyl- butanoyl]amino]-3-[(1-carbamoyl-2-phenyl-ethyl) carbamoyl]propanoic acid
Identifiers
CAS number	25126-32-3
ATC code	V04CC03
PubChem	32800
Chemical data
Formula	C₄₉H₆₂N₁₀O₁₆S₃
Mol. mass	1143.27 g/mol
Synonyms	1-De(5-oxo-L-proline)-2-de-L-glutamine- 5-L-methioninecaerulein
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	B(US)
Legal status	℞-only(US) Available on a named-patient basis (UK)
Routes	Intravenous

Sincalide (INN) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin.

Category: Peptide hormones